Skip to content

Human Yersinia IgG Lateral flow dipstick kit 4672

$487.00

Summary

  • Mikrogen diagnostik lateral flow device (dipstick) for research use (RUO)
  • Human Yersinia IgG Lateral flow dipstick kit 4672
  • Suitable for IgG detection
  • Ready-to-use
  • 20 tests
SKU: 4672 Category: Tags: , ,
Weight1 lbs
Dimensions9 × 5 × 2 in
target

Human Yersinia IgG

species reactivity

Yersinia enterocolitica, Yersinia pseudotuberculosis

applications

Lateral flow (dipstick)

assay type

Indirect & qualitative

available sizes

20 test kits

Human Yersinia IgG Lateral flow dipstick kit 4672

kit
Assay type
Sandwich assay, lateral flow (dipstick)
Research area
Infectious Disease
Sample type
Serum, plasma, whole blood
Components
10X Wash Buffer100 mL
TMB Substrate40 mL
Milk Powder5 g
Instructions for Use1 Each
Evaluation Form1 Each
Test Strips2 kits of [2 Vials x 10 Each]
Anti-Human IgG Conjugate500 μL
Positive Control140 μL
Negative Control140 μL
Storage
Store at 2-8°C.
Additional information
Mikrogen recomLine Yersinia Assays

For the Mikrogen recomLine Yersinia assays, the plasmid-encoded virulence proteins (Yersinia Outer Proteins) localized at the cell surface and adhesins for serological species differentiation between Y. enterocolitica and Y. pseudotuberculosis are produced recombinantly. These proteins are expressed only by human pathogenic Yersinia strains.

The recomLine Yersinia tests allow the detection of long-standing Yersinia infections and are thus ideally suited to identify Yersinia-induced immunopathological complications and chronic yersinioses. The detection of IgG and IgA antibodies can be an important aid in suspected Yersinia-induced arthritis.

Advantages
  • Detection of all human pathogenic Yersinia by means of Yersinia Outer Proteins (YOPs).
  • Differentiation between Y. enterocolitica and Y. pseudotuberculosis infection serologically possible by using new species-specific Yersinia antigens (PsaA, MyfA).
  • No cross-reactions to Brucella and other pathogens, and no interference by LPS.
  • Separate detection of IgG, IgA, and IgM antibodies - antibody class control on the test strip - helpful in case of suspected Yersinia-induced arthritis.
  • Partial and full automation, software-based evaluation (recomScan), and connection to the laboratory information system possible.
  • Highest sensitivity and specificity by using different, recombinant Yersinia antigens.
Bands
AntigenDescription
YOP MYersinia outer protein
V-AGYersinia virulence factor
PsaAAdhesin (specific for Y. pseudotuberculosis)
YOP DYersinia outer protein
MyfAAdhesin (specific for Y. enterocolitica)
YOP EYersinia outer protein
target relevance
Organism
Yersinia enterocolitica
Structure and strains
Yersinia enterocolitica is a Gram-negative, rod-shaped bacterium, belonging to the family Yersiniaceae. It is motile at temperatures of 22 29°C (72 84°F), but becomes nonmotile at normal human body temperature. Y. enterocolitica infection causes the disease yersiniosis, which is an animal-borne disease occurring in humans, as well as in a wide array of animals such as cattle, deer, pigs, and birds. Many of these animals recover from the disease and become carriers; these are potential sources of contagion despite showing no signs of disease. The bacterium infects the host by sticking to its cells using trimeric autotransporter adhesins.
Disease
Yersinia are distributed globally in temperate and subtropical areas. The gram-negative bacteria express a range of plasmidencoded virulence factors, referred to as Yersinia Outer Proteins (YOPs). These molecules influence signal cascades within cells and inhibit the immune response of the host.

The human pathogenic bacteria Y. enterocolitica and Y. pseudotuberculosis may cause inflammation of the intestine (enteritis) associated with stomach pain, diarrhea and vomiting. The disease symptoms are often difficult to distinguish from appendicitis (pseudoappendicitis). Possible postinfectious sequelae include reactive arthritis and erythema nodosum. These complications are frequently apparent in individuals carrying the HLA-B27 gene. Furthermore, cases of acute glomerulonephritis and myocarditis have been described. In patients with weakened immune systems, the disease may take a septic course.
Detection and diagnosis
The use of sensitive and specific ELISA with quantitative determination of IgG, IgM and IgA antibodies is the method of choice for a clear differentiation between acute and chronic yersiniosis. The determination of the individual antibody activities is important for the differential diagnosis of post-infectious sequelae such as rheumatoid arthritis or erythema nodosum. Following the normal course of an acute Yersinia infection, IgG antibody activity often persists for several years while the IgA and IgM antibody activities decrease within a few months post infection. By contrast, in the case of postinfection complications, the IgA antibody activity remains elevated for years.

Publications

pmidtitleauthorscitation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

relevant to this product
4672 protocol
#
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.